IndraLab

Statements

P5091 inhibits NPC. 1 / 1

| 1

reach

"Consistently, in vitro (Fig. 7e, f and Supplementary Fig. 10c–e) and in vivo (Fig. 7g, h) assays showed that USP7 inhibitor P5091 enhanced the antitumor effect of cisplatin in NPC, and this process was enhanced after knockdown of TOP2A."

38287116

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P5091 inhibits NPC. 1 / 1

INDRA sources:

Databases

Reading